Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.

Saved in:
Bibliographic Details
Title: Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.
Authors: Busse P; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Zanichelli A; Operative Unit of Medicine, Angioedema Center, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy., Bernstein JA; University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA., Anderson J; Clinical Research, AllerVie Health, Birmingham, AL, USA., Betschel S; Division of Clinical Immunology and Allergy, University of Toronto, Toronto, ON, Canada., Castaner DN; Takeda Development Center Americas, Inc., Lexington, MA, USA., Otule M; Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA., Piccolo T; Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA. tara.piccolo@takeda.com., Lumry WR; Allergy and Asthma Research Associates, Dallas, TX, USA.
Source: Clinical reviews in allergy & immunology [Clin Rev Allergy Immunol] 2026 Aug 08; Vol. 69 (1). Date of Electronic Publication: 2026 Aug 08.
Publication Type: Journal Article; Review
Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9504368 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-0267 (Electronic) Linking ISSN: 10800549 NLM ISO Abbreviation: Clin Rev Allergy Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1559-0267
DOI:10.1007/s12016-026-09179-x